Drug archive
Chromic Phosphate P 32 (Therapeutic)Before Using
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Before Using This Medicine
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For chromic phosphate P 32, the following should be considered:
Pregnancy - Radiopharmaceuticals are usually not recommended for use during pregnancy to avoid exposing the fetus to radiation. However, some treatment using radiopharmaceuticals may be required even during pregnancy. Be sure you have discussed this with your doctor.
Breast-feeding - Chromic phosphate P 32 passes into the breast milk. If you must receive this radiopharmaceutical, it may be necessary for you to stop breast-feeding during treatment. Be sure you have discussed this with your doctor.
Children - There is no specific information comparing use of chromic phosphate P 32 in children with use in other age groups.
Older adults - Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults. Although there is no specific information comparing use of chromic phosphate P 32 in the elderly with use in other age groups, this medicine is not expected to cause different side effects or problems in older people than it does in younger adults.
Preparation for This Treatment
Your doctor may have special instructions for you in preparation for your treatment. If you have not received such instructions or if you do not understand them, check with your doctor in advance.